Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A. Wender

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Journal of the American Chemical Society|May 2, 2002
Total synthesis of (-)-laulimalidePaul A Wender, Sayee G Hegde, Robert D Hubbard, et al.
ACS Chemical Biology|September 4, 2019
Vancomycin-Arginine Conjugate Inhibits Growth of Carbapenem-Resistant <i>E. coli</i> and Targets Cell-Wall SynthesisAlexandra Antonoplis, Xiaoyu Zang, Tristan Wegner, et al.
Organic Letters|March 4, 2010
Highly efficient, facile, room temperature intermolecular [5 + 2] cycloadditions catalyzed by cationic rhodium(I): one step to cycloheptenes and their librariesPaul A Wender, Lauren E Sirois, René T Stemmler, et al.
Journal of Natural Products|September 23, 2009
An approach to the site-selective diversification of apoptolidin A with peptide-based catalystsChad A Lewis, Kate E Longcore, Scott J Miller, et al.
The Journal of Organic Chemistry|November 15, 2022
Trimethylene Methane Dianion Equivalent for the Asymmetric Consecutive Allylation of Aldehydes: Applications to Prins-Driven Macrocyclizations for the Synthesis of Bryostatin 1 and AnaloguesPaul A Wender, Quang H Luu-Nguyen, Jack L Sloane, et al.
Molecular Pharmaceutics|July 30, 2008
Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategySusan L Mooberry, Michael K Hilinski, Erin A Clark, et al.
Oncotarget|February 7, 2012
"Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivoBrian A DeChristopher, Alice C Fan, Dean W Felsher, et al.
Accounts of Chemical Research|December 28, 2007
Function-oriented synthesis, step economy, and drug designPaul A Wender, Vishal A Verma, Thomas J Paxton, et al.
Accounts of Chemical Research|May 24, 2013
Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applicationsErika Geihe Stanzl, Brian M Trantow, Jessica R Vargas, et al.
Bioconjugate Chemistry|September 15, 2015
Bioorthogonal Catalysis: A General Method To Evaluate Metal-Catalyzed Reactions in Real Time in Living Systems Using a Cellular Luciferase Reporter SystemHsiao-Tieh Hsu, Brian M Trantow, Robert M Waymouth, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Journal of the American Chemical Society|May 2, 2002
Total synthesis of (-)-laulimalidePaul A Wender, Sayee G Hegde, Robert D Hubbard, et al.
ACS Chemical Biology|September 4, 2019
Vancomycin-Arginine Conjugate Inhibits Growth of Carbapenem-Resistant <i>E. coli</i> and Targets Cell-Wall SynthesisAlexandra Antonoplis, Xiaoyu Zang, Tristan Wegner, et al.
Organic Letters|March 4, 2010
Highly efficient, facile, room temperature intermolecular [5 + 2] cycloadditions catalyzed by cationic rhodium(I): one step to cycloheptenes and their librariesPaul A Wender, Lauren E Sirois, René T Stemmler, et al.
Journal of Natural Products|September 23, 2009
An approach to the site-selective diversification of apoptolidin A with peptide-based catalystsChad A Lewis, Kate E Longcore, Scott J Miller, et al.
The Journal of Organic Chemistry|November 15, 2022
Trimethylene Methane Dianion Equivalent for the Asymmetric Consecutive Allylation of Aldehydes: Applications to Prins-Driven Macrocyclizations for the Synthesis of Bryostatin 1 and AnaloguesPaul A Wender, Quang H Luu-Nguyen, Jack L Sloane, et al.
Molecular Pharmaceutics|July 30, 2008
Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategySusan L Mooberry, Michael K Hilinski, Erin A Clark, et al.
Oncotarget|February 7, 2012
"Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivoBrian A DeChristopher, Alice C Fan, Dean W Felsher, et al.
Accounts of Chemical Research|December 28, 2007
Function-oriented synthesis, step economy, and drug designPaul A Wender, Vishal A Verma, Thomas J Paxton, et al.
Accounts of Chemical Research|May 24, 2013
Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applicationsErika Geihe Stanzl, Brian M Trantow, Jessica R Vargas, et al.
Bioconjugate Chemistry|September 15, 2015
Bioorthogonal Catalysis: A General Method To Evaluate Metal-Catalyzed Reactions in Real Time in Living Systems Using a Cellular Luciferase Reporter SystemHsiao-Tieh Hsu, Brian M Trantow, Robert M Waymouth, et al.
Pageof 17